on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has filed Form 8.3 regarding its position in Mural Oncology plc. As of September 22, 2025, Vanguard disclosed its interest in 664,792 $0.01 ordinary shares, representing 3.85% of Mural Oncology's relevant securities.
The filing, made under Rule 8.3 of the Irish Takeover Panel Act, 1997, includes information about purchases and sales of securities. Vanguard purchased 32 shares at $2.07 each and sold 55,500 and 7,049 shares at prices of $2.07 and $2.08, respectively.
No cash-settled or stock-settled derivatives, agreements, or other dealings have been disclosed. Additionally, there are no indemnities, agreements, or understandings related to options or voting rights specified in the form.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news